Kura Oncology, Inc. (NASDAQ:KURA), a clinical-stage biopharmaceutical company focused on developing precision medicines for ...

Patients Achieved Remission Within 30 Days in Cohort 1 of the Mipletamig RAINIER Dose Optimization Trial for Frontline AML Patients, Trial Enrollment ContinuesPromising Data, including a 59% Stable ...

MRD revenue was $40.1 million for the quarter ... Use of Non-GAAP Financial Measure To supplement our unaudited consolidated statements of operations and unaudited consolidated balance sheets, which ...

Reports Q4 revenue $47.46M, consensus $46.05M. “2024 was a year of strong execution, marked by key catalysts achieved in our MRD business and ...

H.C. Wainwright maintained its optimistic stance on Immix Biopharma , Inc. (NASDAQ:IMMX), with analyst Robert Burns reiterating a Buy rating and a $7.00 price target on the company's shares. Currently ...

These distributions can have significant practical, financial, and tax implications. However, RMD rules, which apply to a range of retirement savings plans, have changed. For example, a few years ...

The Supreme Court recently reiterated that further investigation can be directed even after the chargesheet has been filed ...

A bill introduced to the New York state Senate is seeking to bolster the disclosures that reverse mortgage lenders make to potential clients.

The great obesity drug scare of 2023 is now behind ResMed as evidence in the December quarter suggests GLP-1s are actually a ...

On June 6, 1944, allied troops landed on the beaches of Normandy, France to fight Nazi Germany The Gory Origins of Valentine's Day (02:50) National Treasure: The Mold Behind the Miracle of ...

Leading brokers have named ResMed Inc. (ASX: RMD) and these ASX shares as buys this week. Here's why they are bullish on ...